Related Experiment Videos
[Interferons in the treatment of solid tumors. A general review]
1Service de médecine oncologique, Institut Curie, Paris, France.
Abstract:
A potential activity of interferons in the treatment of solid tumors has been suggested by in vitro experiments and, more recently, by phase I trials. Phase II trials have demonstrated a possible antitumoral activity in treating some solid tumors: malignant melanoma, renal cell carcinoma, ovarian adenocarcinoma, carcinoid tumor, superficial bladder cancer. Further trials are necessary to establish the precise role of interferons in treating solid tumors, when administered alone or in combination.
Insights
Interferons show potential anti-tumor activity against solid tumors like melanoma and kidney cancer. Further research is needed to confirm their role in cancer treatment, alone or combined with other therapies.
Area of Science:
- Oncology
- Immunology
Context:
- In vitro studies and early phase trials suggest interferons may treat solid tumors.
- Phase II trials provide preliminary evidence of anti-tumoral effects.
Purpose:
- To evaluate the potential anti-tumoral activity of interferons in various solid tumors.
- To explore the role of interferons in cancer therapy.
Summary:
- Interferons have demonstrated possible anti-tumoral activity in malignant melanoma, renal cell carcinoma, ovarian adenocarcinoma, carcinoid tumors, and superficial bladder cancer.
- Further clinical trials are required to ascertain the definitive role of interferons in solid tumor treatment.
Impact:
- Highlights the potential of interferons as a therapeutic agent for specific solid tumors.
- Underscores the need for continued investigation into interferon-based cancer therapies.